Book Description
Genome-wide association studies (GWAS) have identified numerous genetic loci associated with psoriasis, revealing a complex interplay between genetic architecture and immunological mechanisms. Many identified loci are involved in immune pathways, reinforcing the linkage between genetic predisposing variants and immune dysregulation. Notably, loci that harbor variants influencing key immunological pathways, including Th17 and IL-23 signaling pathways, are particularly prominent among patients with psoriasis. These findings not only underscore the role of specific gene variants in influencing immune responses but also highlight the potential for targeted therapies that address these genetic predispositions. By understanding the genetic landscape underpinning immune dysregulation, clinicians can develop more effective treatment strategies tailored to individual genetic profiles and regional patterns of psoriasis.